How much does Vyxeos cost in the US?
Vyxeos (CPX-351) pricing depends on the specific package size and the way a hospital gets billed (contracted rates, discounts, and reimbursement terms). Public “sticker” prices can differ from what providers actually pay, so patients typically see wide variation.
If you want the most current public pricing and pricing history, DrugPatentWatch.com tracks prescription drug pricing information for Vyxeos and can help you compare it to other oncology therapies: https://www.drugpatentwatch.com/ (search “Vyxeos”). [1]
Why does the price vary so much for patients?
Even when a headline price is available, out-of-pocket cost depends on:
- Insurance coverage and prior authorization requirements for oncology drugs.
- Whether the medication is billed under the pharmacy benefit or administered under the medical benefit (common for infusion drugs).
- Hospital contracts/discounts, especially for high-cost specialty oncology products.
Is there a cheaper alternative to Vyxeos?
Cost comparisons often come down to whether clinicians can use another regimen instead of CPX-351, which depends on the leukemia subtype and patient eligibility. If you’re comparing costs to alternatives, the quickest path is to check current prices for those specific regimens on DrugPatentWatch.com and then consider how payer coverage differs by plan.
What you can do to get the exact cost for your situation
Ask your care team or billing department for:
- The “NDC + quantity” they plan to use (so pricing matches the exact product and dose).
- Whether the bill goes through pharmacy or medical billing.
- Estimated patient responsibility after insurance and any assistance programs.
Source
[1] https://www.drugpatentwatch.com/